118 related articles for article (PubMed ID: 15842050)
21. Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results.
Venturoli S; Cricca M; Bonvicini F; Giosa F; Pulvirenti FR; Galli C; Musiani M; Zerbini M
J Clin Virol; 2002 Aug; 25(2):177-85. PubMed ID: 12367652
[TBL] [Abstract][Full Text] [Related]
22. Does the interval between papanicolaou tests influence the quality of cytology?
Jeronimo J; Khan MJ; Schiffman M; Solomon D;
Cancer; 2005 Jun; 105(3):133-8. PubMed ID: 15822121
[TBL] [Abstract][Full Text] [Related]
23. Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV.
Qureshi MN; Rudelli RD; Tubbs RR; Biscotti CV; Layfield LJ
Diagn Cytopathol; 2003 Sep; 29(3):149-55. PubMed ID: 12951683
[TBL] [Abstract][Full Text] [Related]
24. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
25. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
[TBL] [Abstract][Full Text] [Related]
26. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Castle PE; Solomon D; Schiffman M; Wheeler CM
J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
[TBL] [Abstract][Full Text] [Related]
28. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
[TBL] [Abstract][Full Text] [Related]
29. PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection.
Castle PE; Schiffman M; Herrero R; Hildesheim A; Rodriguez AC; Bratti MC; Wacholder S; Kendal H; Breheny AM; Prior A; Pfeiffer R; Burk RD
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):256-60. PubMed ID: 15668503
[TBL] [Abstract][Full Text] [Related]
30. High-risk human papillomavirus DNA test results are useful for disease risk stratification in women with unsatisfactory liquid-based cytology pap test results.
Zhao C; Austin RM
J Low Genit Tract Dis; 2009 Apr; 13(2):79-84. PubMed ID: 19387127
[TBL] [Abstract][Full Text] [Related]
31. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.
Carozzi F; Bisanzi S; Sani C; Zappa M; Cecchini S; Ciatto S; Confortini M
J Clin Microbiol; 2007 Feb; 45(2):364-9. PubMed ID: 17122008
[TBL] [Abstract][Full Text] [Related]
32. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
Cox JT; Lorincz AT; Schiffman MH; Sherman ME; Cullen A; Kurman RJ
Am J Obstet Gynecol; 1995 Mar; 172(3):946-54. PubMed ID: 7892889
[TBL] [Abstract][Full Text] [Related]
34. Comparison of detection sensitivity for human papillomavirus between self-collected vaginal swabs and physician-collected cervical swabs by electrochemical DNA chip.
Nilyanimit P
Asian Pac J Cancer Prev; 2014; 15(24):10809-12. PubMed ID: 25605181
[TBL] [Abstract][Full Text] [Related]
35. Stability of archived liquid-based cervical cytologic specimens.
Castle PE; Solomon D; Hildesheim A; Herrero R; Concepcion Bratti M; Sherman ME; Cecilia Rodriguez A; Alfaro M; Hutchinson ML; Terence Dunn S; Kuypers J; Schiffman M
Cancer; 2003 Apr; 99(2):89-96. PubMed ID: 12704688
[TBL] [Abstract][Full Text] [Related]
36. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
37. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.
Lin CJ; Lai HC; Wang KH; Hsiung CA; Liu HW; Ding DC; Hsieh CY; Chu TY
Am J Obstet Gynecol; 2011 Jan; 204(1):21.e1-7. PubMed ID: 20833385
[TBL] [Abstract][Full Text] [Related]
38. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
39. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
[TBL] [Abstract][Full Text] [Related]
40. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
